HAE Haemonetics PE ratio, current and historical analysis
As of Apr 2, 2025, the HAE stock has a PE ratio of 25.02. The calculation is based on the latest EPS of $2.56 and the stock price of $64.04 per share. A decrease of 27% has been observed in the PE ratio compared to its average of 34.1 of the last four quarters.
HAE PE ratio history
The mean historical PE ratio of Haemonetics over the last ten years is 107.57. The current 25.02 P/E ratio is 77% lower than the historical average. Looking back at the last ten years, HAE's PE ratio peaked in the Sep 2017 quarter at 641, with a price of $44.87 and an EPS of $0.07. The Dec 2024 quarter marked the lowest point at 30.3, with a price of $77.57 and an EPS of $2.56.
Haemonetics PE ratio by year
Maximum annual increase: 183.71% in 2015
Maximum annual decrease: -51.48% in 2023
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 36.79 | 0.93% | $85.35 | $2.32 |
| 2023 | 36.45 | -51.48% | $82.75 | $2.27 |
| 2022 | 75.12 | 5.27% | $63.85 | $0.85 |
| 2021 | 71.36 | 6.75% | $112.04 | $1.57 |
| 2020 | 66.85 | -18.24% | $100.95 | $1.51 |
| 2019 | 81.76 | -3.89% | $87.48 | $1.07 |
| 2018 | 85.07 | N/A | $73.16 | $0.86 |
| 2017 | N/A | N/A | $40.57 | -$0.51 |
| 2016 | N/A | N/A | $35.29 | -$1.09 |
| 2015 | 133.97 | 183.71% | $44.21 | $0.33 |
| 2014 | 47.22 | -13.86% | $32.11 | $0.68 |
| 2013 | 54.82 | 107.73% | $41.66 | $0.76 |
| 2012 | 26.39 | 26.09% | $34.84 | $1.32 |
| 2011 | 20.93 | -14.78% | $33.29 | $1.59 |
| 2010 | 24.56 | 4.96% | $28.24 | $1.15 |
Haemonetics PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Dec 2024 | 30.3 | -7.73% | $77.57 | $2.56 |
| Sep 2024 | 32.84 | -10.3% | $79.8 | $2.43 |
| Jun 2024 | 36.61 | -0.49% | $82.73 | $2.26 |
| Mar 2024 | 36.79 | 7.57% | $85.35 | $2.32 |
| Dec 2023 | 34.2 | -3.42% | $85.51 | $2.5 |
| Sep 2023 | 35.41 | 11.88% | $89.58 | $2.53 |
| Jul 2023 | 31.65 | -13.17% | $85.14 | $2.69 |
| Apr 2023 | 36.45 | -12.88% | $82.75 | $2.27 |
| Dec 2022 | 41.84 | -5.06% | $78.65 | $1.88 |
| Oct 2022 | 44.07 | -13.59% | $74.03 | $1.68 |
| Jul 2022 | 51 | -32.11% | $67.32 | $1.32 |
| Apr 2022 | 75.12 | -39.1% | $63.85 | $0.85 |
| Jan 2022 | 123.35 | 4.51% | $53.04 | $0.43 |
| Oct 2021 | 118.03 | 125.08% | $72 | $0.61 |
| Jul 2021 | 52.44 | -26.51% | $66.6 | $1.27 |
HAE average PE ratio chart
The current PE ratio of HAE is lower than its 3, 5 and 10-year averages.
HAE PE vs peers
In comparison to its peer stocks JNJ and TMO, HAE's PE ratio is lower. Haemonetics's PE ratio is trading below the peer average of 33.79.
| Stock name | PE ratio | Market cap |
|---|---|---|
| HAE Haemonetics Corp | 24.54 | $3.16B |
| MDT Medtronic plc | 26.6 | $112.92B |
| JNJ Johnson & Johnson | 27.3 | $383.85B |
| TMO Thermo Fisher Scientific Inc | 28.55 | $178.57B |
| BDX Becton Dickinson & Co | 37.25 | $63.75B |
| SYK Stryker Corp | 46.91 | $140.7B |
| CERS Cerus Corp | N/A | $246.17M |
| BAX Baxter International Inc | N/A | $16.26B |
Frequently asked questions
What is Haemonetics's PE ratio?
As of Apr 2, 2025, HAE stock has a price to earnings ratio of 25.02.
What is the 3-year average PE ratio for Haemonetics (HAE)?
The 3-year average price to earnings ratio for HAE stock is 37.38.
What is the 5-year average PE ratio for Haemonetics (HAE)?
The 5-year average price to earnings ratio for HAE stock is 52.36.
What is the highest PE ratio for HAE?
Over the last ten years, the quarterly PE ratio reached its highest level at 641 in the Sep 2017 quarter.
How does the current PE ratio for HAE compare to its historical average?
HAE's current price to earnings ratio is 77% below its 10-year historical average.
How is HAE's PE ratio calculated (Haemonetics PE ratio formula)?
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Apr 2, 2025), Haemonetics's share price is $64.04. The company's earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $2.56. Therefore, Haemonetics's PE ratio for today is 25.02. PE RATIO(25.02) = STOCK PRICE($64.04) / TTM EPS($2.56)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.